| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |